Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04112810Phase 2Completed
Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
Hematologic Malignancies
PrincipalinvestigatorStart date: 2020-03-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Medical College of Wisconsin

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04112810Phase 2PrincipalInvestigator

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

Hematologic Malignancies
Completed
NCT02206035Phase 2PrincipalInvestigator

A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplantation
Completed

All 2 trials loaded